Stock Events

Stock Events

Oncology Pharma 

$0.050200
8
+$0.00+0.4% Wednesday 16:44

Statistics

Day High
0.0501
Day Low
0.0501
52W High
0.364
52W Low
0.0001
Volume
200
Avg. Volume
24,492
Mkt Cap
4.12M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

31DecExpected
Q4 2016
Q1 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
-1
-0.67
-0.34
-0.01
Expected EPS
N/A
Actual EPS
-0.0119

Financials

-Profit Margin
Unprofitable
2016
2017
2018
2019
2020
2021
0Revenue
-104.63MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ONPH. It's not an investment recommendation.
Microsoft
2
MSFT
Coca-Cola
2
KO
JPMorgan Equity Premium Income
2
JEPI
Verizon Communications
2
VZ

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Merck
MRK
Mkt Cap305.12B
Merck & Co., Inc. is a leading pharmaceutical company that develops cancer treatments, directly competing with Oncology Pharma's oncology-focused drug development.
Bristol-Myers Squibb
BMY
Mkt Cap117.58B
Bristol-Myers Squibb is involved in the discovery, development, and delivery of cancer treatments, making it a direct competitor in the oncology sector.
Pfizer
PFE
Mkt Cap137.76B
Pfizer Inc. has a significant portfolio of oncology drugs, competing in the same market as Oncology Pharma for cancer treatment solutions.
Roche
RHHBY
Mkt Cap334.28B
Roche Holding AG, through its pharmaceuticals division, focuses on oncology drugs, directly competing with Oncology Pharma in the cancer treatment space.
Novartis
NVS
Mkt Cap293.94B
Novartis AG is a global healthcare company that has a strong focus on oncology, making it a competitor in the development and marketing of cancer treatments.
Astrazeneca
AZN
Mkt Cap266.15B
AstraZeneca PLC has a significant pipeline and portfolio of oncology products, competing with Oncology Pharma in the research and development of cancer therapies.
Gilead Sciences
GILD
Mkt Cap161.19B
Gilead Sciences, Inc. is known for its innovative therapies in oncology, directly competing with Oncology Pharma in the cancer treatment market.
AMGEN
AMGN
Mkt Cap196.12B
Amgen Inc. focuses on human therapeutics, including oncology, competing with Oncology Pharma in the development of cancer treatments.
Johnson & Johnson
JNJ
Mkt Cap618.61B
Johnson & Johnson, through its pharmaceutical segment, develops and sells oncology drugs, making it a competitor in the cancer treatment market.
Abbvie
ABBV
Mkt Cap438.31B
AbbVie Inc. has a growing oncology portfolio, directly competing with Oncology Pharma in the development and commercialization of cancer treatments.

About

Oncology Pharma Inc. is a pharmaceutical firm specializing in oncology, dedicated to the development, manufacturing, and commercialization of therapeutic agents. The company has a collaborative and licensing agreement with Kalos Therapeutics Inc. to explore treatment possibilities for the COVID-19 virus. Originally incorporated in 1993, the company was known as SourcingLink.net Inc. until it rebranded as Oncology Pharma Inc. in June 2019. Its operations are based in San Francisco, California.
Show more...
CEO
Mr. Chuck Wagner
Employees
1
Country
United States
ISIN
US68235J2015

Listings

OTC Link
US
ONPH

0 Comments

Share your thoughts

FAQ

What is Oncology Pharma stock price today?▼
The current price of ONPH is $0.05 USD — it has increased by +0.4% in the past 24 hours. Watch Oncology Pharma stock price performance more closely on the chart.
What is Oncology Pharma stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Oncology Pharma stocks are traded under the ticker ONPH.
Is Oncology Pharma stock price growing?▼
ONPH stock has fallen by -28.29% compared to the previous week, the month change is a -28.29% fall, over the last year Oncology Pharma has showed a +2,410% increase.
What is Oncology Pharma market cap?▼
Today Oncology Pharma has the market capitalization of 4.12M
What were Oncology Pharma earnings last quarter?▼
ONPH earnings for the last quarter are -0.01 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Oncology Pharma revenue for the last year?▼
Oncology Pharma revenue for the last year amounts to 0 USD.
What is Oncology Pharma net income for the last year?▼
ONPH net income for the last year is -104.63M USD.
How many employees does Oncology Pharma have?▼
As of July 30, 2026, the company has 1 employees.
In which sector is Oncology Pharma located?▼
Oncology Pharma operates in the Health & Wellness sector.
When did Oncology Pharma complete a stock split?▼
The last stock split for Oncology Pharma was on October 09, 2020 with a ratio of 1:100.
Where is Oncology Pharma headquartered?▼
Oncology Pharma is headquartered in San Francisco, United States.